Literature DB >> 18625525

Cardiovascular manifestations associated with influenza virus infection.

Mamas Andreas Mamas1, Doug Fraser, Ludwig Neyses.   

Abstract

Influenza accounts for 3 to 5 million cases of severe illness and up to 300,000 deaths annually. Cardiovascular involvement in acute influenza infection can occur through direct effects of the virus on the myocardium or through exacerbation of existing cardiovascular disease. Epidemiological studies have demonstrated an association between influenza epidemics and cardiovascular mortality and a decrease in cardiovascular mortality in high risk patients has been demonstrated following vaccination with influenza vaccine. Influenza is a recognised cause of myocarditis which can lead to significant impairment of cardiac function and mortality. With recent concerns regarding another potential global pandemic of influenza the huge potential for cardiovascular morbidity and mortality is discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18625525     DOI: 10.1016/j.ijcard.2008.04.044

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  84 in total

Review 1.  Neurologic and muscular complications of the 2009 influenza A (H1N1) pandemic.

Authors:  Larry E Davis
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

2.  Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus.

Authors:  Simona Puzelli; Franco M Buonaguro; Marzia Facchini; Annapina Palmieri; Laura Calzoletti; Maria A De Marco; Pasquale Arace; Enrico de Campora; Ciro Esposito; Antonio Cassone; Giovanni Rezza; Isabella Donatelli
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

Review 3.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

4.  Seasonal Influenza Infections and Cardiovascular Disease Mortality.

Authors:  Jennifer L Nguyen; Wan Yang; Kazuhiko Ito; Thomas D Matte; Jeffrey Shaman; Patrick L Kinney
Journal:  JAMA Cardiol       Date:  2016-06-01       Impact factor: 14.676

Review 5.  Global burden of influenza as a cause of cardiopulmonary morbidity and mortality.

Authors:  William A Fischer; Michelle Gong; Satish Bhagwanjee; Jonathan Sevransky
Journal:  Glob Heart       Date:  2014-10-31

6.  Unusual association of ST-T abnormalities, myocarditis and cardiomyopathy with H1N1 influenza in pregnancy: two case reports and review of the literature.

Authors:  Karen Chan; David Meek; Indranil Chakravorty
Journal:  J Med Case Rep       Date:  2011-07-14

7.  Fatal influenza myocarditis with incessant ventricular tachycardia.

Authors:  Nidhi Saraiya; Supriya Singh; Marilou Corpuz
Journal:  BMJ Case Rep       Date:  2019-07-01

8.  Acute Influenza Infection Presenting with Cardiac Tamponade: A Case Report and Review of Literature.

Authors:  Yadav Pandey; Rimsha Hasan; Krishna P Joshi; Fuad J Habash; Rajani Jagana
Journal:  Perm J       Date:  2019

9.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

10.  Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.

Authors:  Eric J Chow; Melissa A Rolfes; Alissa O'Halloran; Evan J Anderson; Nancy M Bennett; Laurie Billing; Shua Chai; Elizabeth Dufort; Rachel Herlihy; Sue Kim; Ruth Lynfield; Chelsea McMullen; Maya L Monroe; William Schaffner; Melanie Spencer; H Keipp Talbot; Ann Thomas; Kimberly Yousey-Hindes; Carrie Reed; Shikha Garg
Journal:  Ann Intern Med       Date:  2020-08-25       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.